Sensipar
New Genetic Link Found Between Normal Fetal Growth and Cancer »
"Two researchers at the National Institutes of Health discovered a new genetic link between the rapid growth of healthy fetuses and the uncontrolled cell division in cancer. The findings shed light on normal development and on the genetic under"...
Read the New Genetic Link Found Between Normal Fetal Growth and Cancer article »
Sensipar
OVERDOSE
Doses titrated up to 300 mg once daily have been safely administered to patients on dialysis. Overdosage of Sensipar (cinacalcet) may lead to hypocalcemia. In the event of overdosage, patients should be monitored for signs and symptoms of hypocalcemia and appropriate measures taken to correct serum calcium levels [see WARNINGS AND PRECAUTIONS].
Since Sensipar (cinacalcet) is highly protein bound, hemodialysis is not an effective treatment for overdosage of Sensipar (cinacalcet) .
CONTRAINDICATIONS
Hypocalcemia: Sensipar (cinacalcet) treatment should not be initiated if serum calcium is less than the lower limit of the normal range [see WARNINGS AND PRECAUTIONS].
Last reviewed on RxList: 4/19/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Sensipar Information
Sensipar - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cancer
Get the latest treatment options.






